Landos Biopharma Valuation
| LABPDelisted Stock | USD 4.02 0.15 3.60% |
At this time, the firm appears to be overvalued. Landos Biopharma secures a last-minute Real Value of $3.21 per share. The latest price of the firm is $4.02. Our model forecasts the value of Landos Biopharma from analyzing the firm fundamentals such as Return On Equity of -0.71, shares owned by insiders of 9.88 %, and Current Valuation of 42.67 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Landos Biopharma's price fluctuation is very steady at this time. Calculation of the real value of Landos Biopharma is based on 3 months time horizon. Increasing Landos Biopharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Landos Biopharma's intrinsic value may or may not be the same as its current market price of 4.02, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.02 | Real 3.21 | Hype 4.02 | Naive 4.13 |
The intrinsic value of Landos Biopharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Landos Biopharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Landos Biopharma helps investors to forecast how Landos stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Landos Biopharma more accurately as focusing exclusively on Landos Biopharma's fundamentals will not take into account other important factors: Landos Biopharma Total Value Analysis
Landos Biopharma is now forecasted to have valuation of 42.67 M with market capitalization of 71.68 M, debt of 27 K, and cash on hands of 55.75 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Landos Biopharma fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
42.67 M | 71.68 M | 27 K | 55.75 M |
Landos Biopharma Asset Utilization
One of the ways to look at asset utilization of Landos is to check how much profit was generated for every dollar of assets it reports. Landos Biopharma secures a negative usage of assets of -0.39 %, losing $0.003938 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Landos Biopharma shows how discouraging it operates for each dollar spent on its assets.Landos Biopharma Ownership Allocation
The market capitalization of Landos Biopharma is $71.68 Million. Over half of Landos Biopharma's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Landos Biopharma Profitability Analysis
Net Loss for the year was (21.93 M) with profit before overhead, payroll, taxes, and interest of 18 M.About Landos Biopharma Valuation
The delisted stock valuation mechanism determines Landos Biopharma's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Landos Biopharma based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Landos Biopharma. We calculate exposure to Landos Biopharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Landos Biopharma's related companies.Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company was incorporated in 2017 and is headquartered in Blacksburg, Virginia. Landos Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 46 people.
Landos Biopharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as Landos Biopharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 6.3 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Landos Stock
If you are still planning to invest in Landos Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Landos Biopharma's history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |